Article
Orally bioavailable CB2 receptor agonists attenuate neuroinflammation and stabilize the blood–brain barrier
2026-06-03
Abstract excerpt
<title>Abstract</title> <p> Background Neuroinflammation and blood–brain barrier (BBB) dysfunction are key contributors to the pathogenesis of many neurological disorders. Cannabinoid receptor 2 (CB <sub>2</sub> ) agonists possess anti-inflammatory properties and may represent promising therapeutic agents for preserving BBB integrity. This study evaluated the effects of novel orally bioavailable CB <sub>2</s...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2ca14310-4481-5d84-8b46-75841fc744e4
- DOI
- 10.21203/rs.3.rs-9705876/v1
